Understanding How Ketamine Brings About Rapid Improvement in OCD
Trial ID or NCT#
NCT02624596
Status
NOT RECRUITING
Purpose
The purpose of this study is to understand how ketamine brings about rapid improvement in Obsessive-Compulsive Disorder (OCD) symptoms.
Official Title
NMDAR Modulation As a Therapeutic Target and Probe of Neural Dysfunction in OCD
Eligibility Criteria
Ages Eligible for Study: 18 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: Yes
Investigator(s)
Carolyn Rodriguez
Psychiatrist
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Contact us to find out if this trial is right for you.
Contact
Elizabeth McCarthy
650-723-4095
View on ClinicalTrials.gov
